Scientists at Duke-NUS Medical School and National Heart Center Singapore (NHCS), in collaboration with colleagues in Singapore and the UK, have shown that the human form of the signaling protein interleukin 11 (IL-11) has ...
Jun 18, 2021
0
15
An antibiotic developed in the 1950s and largely supplanted by newer drugs, effectively targets and kills cancer cells with a common genetic defect, laboratory research by Dana-Farber Cancer Institute scientists shows. The ...
Jun 17, 2021
0
217
A cell-penetrating peptide developed by researchers at Vanderbilt University Medical Center can prevent, in an animal model, the often-fatal septic shock that can result from bacterial and viral infections.
Jun 9, 2021
0
114
Neural replay during waking rest may contribute to memory consolidation of action sequences in humans, according to a study published June 8 in the journal Cell Reports. Brain imaging results revealed fast, repeated reactivation ...
Jun 8, 2021
0
190
A novel compound similar in structure to the psychedelic drug ibogaine, but lacking its toxic and hallucinogenic effects, has been found to rapidly reverse the effects of stress in mice.
May 25, 2021
3
172
Chronic inflammation of the pancreas is a debilitating disease with poorly understood causative factors. Now, researchers at Osaka University have identified the disturbed molecular pathways and revealed the underlying mechanisms ...
May 25, 2021
0
16
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) and Yale University have succeeded in reducing the size of the HIV reservoir in humanized mice by using a "molecular can opener" and a combination ...
May 20, 2021
0
4861
UCI scholars Zachary W. Wagoner, a graduate student researcher in cellular & molecular biosciences, and Weian Zhao, professor of pharmaceutical sciences, have identified a new mechanism by which transplanted stem cells treat ...
May 18, 2021
0
66
Researchers at Baylor College of Medicine have followed the progression of breast cancer in an animal model and discovered a path that transforms a slow-growing type of cancer known as estrogen receptor (ER)+/HER2+ into a ...
May 17, 2021
0
49
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed a vaccine that could induce long-term protection against allergic ...
May 17, 2021
0
199
